跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
CSL Hong Kong Aleviate Human Coagulation Factor VIII 250 IU/von Willebrand factor 500 IU complex, Powder for injection (50 IU/mL FVIII)
Approved
STANDARD
CSL Hong Kong Aleviate Human Coagulation Factor VIII 250 IU/von Willebrand factor 500 IU complex, Powder for injection (50 IU/mL FVIII)
CSL Behring (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
b1706d3600ef4837
Company
CSL Behring (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
b1706d3600ef4837
Product Name
CSL Hong Kong Aleviate Human Coagulation Factor VIII 250 IU/von Willebrand factor 500 IU complex, Powder for injection (50 IU/mL FVIII)
Artg Id
425370
Artg Name
CSL Hong Kong Aleviate Human Coagulation Factor VIII 250 IU/von Willebrand factor 500 IU complex, Powder for injection (50 IU/mL FVIII)
Sponsor
CSL Behring (Australia) Pty Ltd
Company Detail Path
/organization/csl-behring-australia-pty-ltd
Artg Date
2023-10-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
b1706d3600ef4837
Type
Standard
Back to TGA Approvals
CSL Hong Kong Aleviate Human Coagulation Factor VIII 250 IU/von Willebrand factor 500 IU complex, Powder for injection (50 IU/mL FVIII) - TGA Drug Approval Details